Key terms
About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NVO news
Nov 18
11:48am ET
Novo Nordisk’s Ambitious Share Buyback Initiative
Nov 18
10:55am ET
UBS Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Nov 15
3:25am ET
Goldman Sachs Sticks to Their Buy Rating for Novo Nordisk (0QIU)
Nov 14
6:31am ET
Novo Nordisk Executives Purchase ADRs on NYSE
Nov 13
9:57am ET
Bank of America Securities Sticks to Its Buy Rating for Novo Nordisk (NVO)
Nov 13
6:34am ET
Novo Nordisk Executives Engage in Share Transactions
Nov 11
10:05am ET
Novo Nordisk placed on ‘Positive Catalyst Watch’ at JPMorgan
Nov 11
9:35am ET
UBS Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Nov 11
7:35am ET
Goldman Sachs Keeps Their Buy Rating on Novo Nordisk (0QIU)
Nov 11
7:34am ET
Buy Rating for Novo Nordisk: Strategic Growth and Market Opportunities Amid Supply Challenges
Nov 11
3:16am ET
J.P. Morgan Keeps Their Buy Rating on Novo Nordisk (0QIU)
Nov 08
5:28pm ET
Novo Nordisk Executives Sell Shares Worth DKK 4.74 Billion
Nov 08
5:18pm ET
Novo Nordisk Expands 2024 Share Repurchase Program
Nov 08
5:18pm ET
Novo Nordisk’s Strategic Share Repurchase Moves
Nov 08
5:18pm ET
Novo Nordisk Reports Insider Trading Activity
Nov 08
6:24am ET
Barclays Sticks to Their Buy Rating for Novo Nordisk (0QIU)
Nov 07
8:36pm ET
Novo Nordisk (0QIU) Gets a Hold from Kepler Capital
Nov 07
3:28pm ET
Novo Nordisk Executives Show Confidence with Share Purchases
Nov 07
3:25pm ET
Novo Nordisk (0QIU) Receives a Hold from UBS
Nov 07
12:25pm ET
Novo Nordisk (0QIU) Receives a Hold from DZ BANK AG
Nov 07
7:37am ET
Deutsche Bank Sticks to Their Buy Rating for Novo Nordisk (0QIU)
Nov 06
11:24pm ET
Novo Nordisk Reports Strong Growth in 2024
Nov 06
9:40am ET
Unusually active option classes on open November 6th
Nov 06
9:23am ET
NVO Earnings: Novo Nordisk Exceeds Q3 Earnings, Narrows Outlook
Nov 06
8:11am ET
Novo Nordisk now sees 2024 sales growth to be 23-27% at CER
Nov 06
8:05am ET
Novo Nordisk reports 9M 2024 EPS DKK 16.29 vs. DKK 13.71 last year
Nov 06
7:50am ET
Analysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), MacroGenics (MGNX) and Novo Nordisk (NVO)
Nov 06
7:35am ET
J.P. Morgan Keeps Their Buy Rating on Novo Nordisk (0QIU)
Nov 06
7:27am ET
Cantor Fitzgerald Reaffirms Their Buy Rating on Novo Nordisk (NVO)
Nov 06
7:01am ET
Novo Nordisk Reports Strong Sales Growth in 2024
Nov 06
5:20am ET
Jefferies Remains a Sell on Novo Nordisk (0QIU)
Yesterday
11:40am ET
PFE vs. NVO: Which Stock Is the Better Value Option?
Yesterday
8:24am ET
Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
Nov 20
3:00pm ET
J&J Loses Around $24B in a Month: How to Play the Stock?
Nov 15
12:54pm ET
Trump Taps RFK for HHS: Time to Avoid Biotech?
Nov 15
10:08am ET
AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?
Nov 14
3:00pm ET
Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
Nov 13
7:48am ET
Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus
Nov 12
9:45am ET
Here's Why Novo Nordisk (NVO) is a Strong Growth Stock
Nov 11
3:00pm ET
Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?
Nov 11
6:20am ET
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Nov 07
8:50am ET
TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase
Nov 06
3:00pm ET
Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings
Nov 06
11:49am ET
NVO Misses Q3 Earnings & Revenue Estimates, Updates 2024 View
Nov 05
3:00pm ET
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
Nov 05
11:40am ET
PFE or NVO: Which Is the Better Value Stock Right Now?
Nov 04
3:00pm ET
Buy, Sell or Hold Pfizer Stock After Q3 Earnings Beat, Guidance Boost?
Nov 04
9:30am ET
Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
Nov 04
9:06am ET
Novo Nordisk Before Q3 Earnings: How Should Investors Play the Stock?
Oct 31
7:43am ET
Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus
Oct 30
11:49am ET
Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks
Oct 30
5:53am ET
The Zacks Analyst Blog Apple, Novo Nordisk, RTX and FONAR
Oct 29
4:19pm ET
Top Research Reports for Apple, Novo Nordisk & RTX
Oct 29
3:00pm ET
Can Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again?
Oct 29
12:15pm ET
Will Higher Expense Level Be a Woe for Humana in Q3 Earnings?
Oct 29
9:33am ET
Zoetis Gears Up to Report Q3 Earnings: What's in the Offing?
Oct 28
5:45pm ET
Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know
Oct 28
10:45am ET
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?
Oct 28
9:00am ET
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
Oct 25
3:00pm ET
Pharma Stock Roundup: RHHBY Earnings, Drug Pipeline & Regulatory News
Oct 25
9:16am ET
Should AbbVie Stock Be in Your Portfolio Pre-Q3 Earnings?
Oct 24
11:48am ET
Precision BioSciences to Report Q3 Earnings: What's in the Cards?
NVO Financials
Key terms
Ad Feedback
NVO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
